CLOSTRIDIOIDES DIFFICILE INFECTION
Clinical trials for CLOSTRIDIOIDES DIFFICILE INFECTION explained in plain language.
Never miss a new study
Get alerted when new CLOSTRIDIOIDES DIFFICILE INFECTION trials appear
Sign up with your email to follow new studies for CLOSTRIDIOIDES DIFFICILE INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a sweetener beat a superbug? new trial tests xylitol for c. diff in IBD
Disease control Not yet recruitingThis early-stage trial tests whether xylitol, a common sugar substitute, can safely clear C. difficile bacteria from the gut in people with inflammatory bowel disease (IBD). About 69 adults with mild or inactive IBD will take xylitol by mouth, and researchers will check if the in…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: EARLY_PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 26, 2026 07:57 UTC
-
Could a sweetener beat a gut infection? new study tests xylitol for c. diff in IBD
Disease control Not yet recruitingThis study tests whether xylitol, a common sweetener, can safely clear C. difficile bacteria from the gut in people with inflammatory bowel disease (IBD). About 99 adults with mild or inactive IBD will take either a low or high dose of xylitol or a placebo for four weeks. Researc…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
New hope for IBD patients: can a better antibiotic stop c. diff for good?
Disease control Not yet recruitingThis study compares two antibiotics, fidaxomicin and vancomycin, to see which one is better at clearing C. difficile bacteria from the gut in people with inflammatory bowel disease (IBD). About 60 adults with IBD will take one of the two antibiotics for 10 days, and researchers w…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New hope against recurrent c. diff: common bile acid shows promise
Prevention Not yet recruitingThis early-phase study tests whether adding a bile acid called UDCA to standard antibiotics can stop C. diff colitis from returning. About 30 adults with high-risk C. diff will take UDCA for up to 8 weeks alongside their usual treatment. Researchers will track recurrence through …
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: EARLY_PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated May 20, 2026 11:55 UTC
-
Fecal transplant vs antibiotics: which works better Long-Term for c. diff?
Knowledge-focused Not yet recruitingThis study looks at adults who had a C. diff infection and were treated with either a fecal transplant (FMT) or antibiotics alone. Researchers want to see if FMT leads to healthier gut bacteria and better long-term outcomes up to 10 years later. Participants provide blood, stool,…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Sponsor: Umeå University • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC